IL164181A0 - Anti-il-tif antibodies and methods of using in inflammation - Google Patents
Anti-il-tif antibodies and methods of using in inflammationInfo
- Publication number
- IL164181A0 IL164181A0 IL16418103A IL16418103A IL164181A0 IL 164181 A0 IL164181 A0 IL 164181A0 IL 16418103 A IL16418103 A IL 16418103A IL 16418103 A IL16418103 A IL 16418103A IL 164181 A0 IL164181 A0 IL 164181A0
- Authority
- IL
- Israel
- Prior art keywords
- inflammation
- methods
- tif antibodies
- tif
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36684202P | 2002-03-22 | 2002-03-22 | |
PCT/US2003/009075 WO2003083062A2 (en) | 2002-03-22 | 2003-03-24 | Anti-il-tif antibodies and methods of using in inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164181A0 true IL164181A0 (en) | 2005-12-18 |
Family
ID=28675288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16418103A IL164181A0 (en) | 2002-03-22 | 2003-03-24 | Anti-il-tif antibodies and methods of using in inflammation |
Country Status (7)
Country | Link |
---|---|
US (5) | US7265211B2 (xx) |
EP (1) | EP1546358A4 (xx) |
JP (2) | JP4504023B2 (xx) |
AU (2) | AU2003223344B9 (xx) |
CA (1) | CA2480163A1 (xx) |
IL (1) | IL164181A0 (xx) |
WO (1) | WO2003083062A2 (xx) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7307161B1 (en) * | 1999-04-28 | 2007-12-11 | Genetics Institute, Llc | Human Gil-19/AE289 polynucleotides |
US6939545B2 (en) | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
CA2393369A1 (en) | 1999-12-03 | 2001-06-07 | Zymogenetics, Inc. | Human cytokine receptor |
US7638604B2 (en) * | 2001-02-23 | 2009-12-29 | Genetics Institute, Llc | Monoclonal antibodies against interleukin-22 |
EP1370676A4 (en) | 2001-03-02 | 2004-09-22 | Zymogenetics Inc | CYTOKIN RECEPTOR FROM MOUSE |
EP1373508B1 (en) | 2001-03-27 | 2013-04-24 | ZymoGenetics, Inc. | Human cytokine receptor |
US7265211B2 (en) | 2002-03-22 | 2007-09-04 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of making |
SE0301109D0 (sv) | 2003-04-14 | 2003-04-14 | Mallen Huang | Nucleotide vaccine composition |
JP2007537993A (ja) * | 2003-11-21 | 2007-12-27 | ザイモジェネティクス, インコーポレイテッド | 抗il−20受容体抗体および結合パートナーならびに炎症において用いる方法 |
DE102005035544A1 (de) * | 2005-07-29 | 2007-02-01 | Paul Hartmann Ag | Inkontinenzartikel |
US7422899B2 (en) * | 2005-10-05 | 2008-09-09 | Biogen Idec Ma Inc. | Antibodies to the human prolactin receptor |
EP1954719A2 (en) | 2005-12-02 | 2008-08-13 | Genentech Inc. | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
TWI417301B (zh) * | 2006-02-21 | 2013-12-01 | Wyeth Corp | 對抗人類介白素-22(il-22)之抗體及其用途 |
TW200744634A (en) * | 2006-02-21 | 2007-12-16 | Wyeth Corp | Methods of using antibodies against human IL-22 |
US9063129B2 (en) * | 2007-06-15 | 2015-06-23 | Idexx Laboratories, Inc. | Device, kit and method for hookworm antigen capture and detection |
US9239326B2 (en) | 2007-06-15 | 2016-01-19 | Idexx Laboratories, Inc. | Compositions, devices, kits and methods for detecting hookworm |
ES2509894T3 (es) * | 2008-05-19 | 2014-10-20 | Idexx Laboratories Inc | Métodos, dispositivos, kits y composiciones para detectar gusano redondo, gusano látigo y gusano de gancho |
US7993861B2 (en) | 2008-05-19 | 2011-08-09 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting whipworm |
BRPI0912982B1 (pt) | 2008-05-19 | 2019-08-27 | Divergence Inc | método para detectar a presença ou ausência de um ou mais antígenos do nematódeo em uma amostra, polipeptídeo isolado, dispositivo para detectar a presença ou ausência de antígenos do nematódeo a partir de uma amostra, e kit para detectar um ou mais antígenos do nematódeo em uma amostra de mamíferos |
WO2009143079A2 (en) * | 2008-05-19 | 2009-11-26 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
WO2009143081A2 (en) * | 2008-05-19 | 2009-11-26 | Idexx Laboratories, Inc. | Methods, devices kits and compositions for detecting roundworm |
KR101499302B1 (ko) | 2009-11-17 | 2015-03-09 | 아이덱스 래보러토리즈, 인코포레이티드 | 회충을 검출하기 위한 방법, 장치, 키트 및 조성물 |
ES2712709T3 (es) | 2010-07-20 | 2019-05-14 | Univ Southern California | Células madre mesenquimales de médula ósea con telomerasa de alta actividad, métodos de producción de las mismas y productos farmacéuticos y métodos de tratamiento basados en las mismas |
JP6456356B2 (ja) | 2013-03-15 | 2019-01-23 | ジェネンテック, インコーポレイテッド | IL−22ポリペプチド及びIL−22Fc融合タンパク質並びに使用方法 |
SG11202012014UA (en) | 2018-06-05 | 2021-01-28 | Bioatla Inc | Anti-il-22 antibodies, antibody fragments, their immunoconjugates and uses thereof |
AU2021398385A1 (en) | 2020-12-07 | 2023-07-13 | UCB Biopharma SRL | Antibodies against interleukin-22 |
CN114539401B (zh) * | 2022-04-26 | 2022-06-24 | 北京科跃中楷生物技术有限公司 | 一种磁微粒标记方法及检测试剂盒 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4443549A (en) | 1981-10-19 | 1984-04-17 | Molecular Genetics, Inc. | Production of monoclonal antibodies against bacterial adhesins |
WO1989004838A1 (en) | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
DE69030383T2 (de) | 1989-10-02 | 1997-10-23 | Univ Arkansas | Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten |
US5843697A (en) | 1996-07-17 | 1998-12-01 | University Of Medicine And Dentistry Of New Jersey | Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein |
US5945511A (en) | 1997-02-20 | 1999-08-31 | Zymogenetics, Inc. | Class II cytokine receptor |
AU737127B2 (en) | 1997-05-06 | 2001-08-09 | Zymogenetics Inc. | Human prohormone convertase 4 |
US5965704A (en) | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
WO2002016611A2 (en) * | 2000-08-24 | 2002-02-28 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
US6551799B2 (en) | 1999-12-07 | 2003-04-22 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
CA2347066C (en) | 1998-10-26 | 2011-05-03 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof |
US6274710B1 (en) | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
EP1141008A1 (en) | 1998-12-31 | 2001-10-10 | Millennium Pharmaceuticals, Inc. | Class ii cytokine receptor-like proteins and nucleic acids encoding them |
NZ515678A (en) | 1999-04-28 | 2004-01-30 | Genetics Inst | Human GIL-19/AE289 proteins and polynucleotides encoding same |
AU5151100A (en) | 1999-05-19 | 2000-12-05 | Incyte Genomics, Inc. | Extracellular signaling molecules |
AU5047600A (en) | 1999-05-27 | 2000-12-18 | Schering Corporation | Mammalian interleukin-10 homologs: il-d110 and il-d210 |
ATE449109T1 (de) | 1999-06-15 | 2009-12-15 | Genentech Inc | Sekretierte und transmembran-polypeptide sowie nukleinsäuren zu deren kodierung |
EP1208202A2 (en) | 1999-09-01 | 2002-05-29 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1230368A2 (en) | 1999-11-18 | 2002-08-14 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
CA2393369A1 (en) | 1999-12-03 | 2001-06-07 | Zymogenetics, Inc. | Human cytokine receptor |
EP1242600B1 (en) * | 1999-12-23 | 2010-03-03 | ZymoGenetics, Inc. | Cytokine zcyto18 |
US20030170823A1 (en) * | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
NZ523122A (en) | 2000-06-22 | 2004-06-25 | Smithkline Beecham Corp | Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases |
ATE478148T1 (de) * | 2000-07-27 | 2010-09-15 | Wyeth Llc | Verwendung von il-10 rezeptor beta antagonistische antikörper zur hemmung einer il- tif/il-21 induktion von akutphasen-proteine |
ATE549347T1 (de) | 2000-09-08 | 2012-03-15 | Schering Corp | Gene von säugetiere, und damit verbundene reagentien, methoden |
US7268223B2 (en) | 2000-09-22 | 2007-09-11 | Wyeth | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
US20030022827A1 (en) | 2000-09-25 | 2003-01-30 | Bertram Weiss | Three new members of the cytokine receptor family class 2 |
EP1191035A3 (de) | 2000-09-25 | 2002-04-17 | Schering Aktiengesellschaft | Drei Mitglieder der Zytokinrezeptorfamilie Klasse II |
NZ527087A (en) | 2001-01-12 | 2008-09-26 | Genetics Inst Llc | Type 2 cytokine receptor and nucleic acids encoding same |
NZ527396A (en) * | 2001-02-23 | 2007-12-21 | Genetics Inst Llc | Antibodies and fragments thereof for the binding of IL-22 and use therefore for treating inflammatory disorders |
WO2002072607A2 (en) | 2001-03-09 | 2002-09-19 | Zymogenetics, Inc. | Soluble heterodimeric cytokine receptor |
US20040204351A1 (en) | 2001-10-22 | 2004-10-14 | Rowlinson Scott William | Soluble proteins that inhibit cytokine signal transduction pathways |
US7265211B2 (en) | 2002-03-22 | 2007-09-04 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of making |
-
2003
- 2003-03-24 US US10/395,741 patent/US7265211B2/en not_active Expired - Lifetime
- 2003-03-24 EP EP03719461A patent/EP1546358A4/en not_active Withdrawn
- 2003-03-24 IL IL16418103A patent/IL164181A0/xx unknown
- 2003-03-24 AU AU2003223344A patent/AU2003223344B9/en not_active Ceased
- 2003-03-24 JP JP2003580498A patent/JP4504023B2/ja not_active Expired - Fee Related
- 2003-03-24 WO PCT/US2003/009075 patent/WO2003083062A2/en active Search and Examination
- 2003-03-24 CA CA002480163A patent/CA2480163A1/en not_active Abandoned
-
2007
- 2007-07-27 US US11/829,755 patent/US7674461B2/en not_active Expired - Lifetime
- 2007-07-27 US US11/829,765 patent/US7718172B2/en not_active Expired - Lifetime
-
2009
- 2009-09-11 AU AU2009213075A patent/AU2009213075B8/en not_active Ceased
-
2010
- 2010-03-09 JP JP2010051579A patent/JP2010220612A/ja active Pending
- 2010-03-25 US US12/732,116 patent/US8524227B2/en active Active
-
2013
- 2013-07-30 US US13/953,975 patent/US8900578B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7265211B2 (en) | 2007-09-04 |
US8900578B2 (en) | 2014-12-02 |
AU2009213075B2 (en) | 2012-07-05 |
US20090022723A1 (en) | 2009-01-22 |
US20120189628A1 (en) | 2012-07-26 |
US7674461B2 (en) | 2010-03-09 |
AU2003223344A2 (en) | 2003-10-13 |
JP2010220612A (ja) | 2010-10-07 |
EP1546358A4 (en) | 2006-06-07 |
EP1546358A2 (en) | 2005-06-29 |
JP4504023B2 (ja) | 2010-07-14 |
WO2003083062A2 (en) | 2003-10-09 |
US7718172B2 (en) | 2010-05-18 |
AU2003223344B2 (en) | 2009-06-11 |
AU2003223344A1 (en) | 2003-10-13 |
AU2003223344B9 (en) | 2009-07-16 |
JP2006508023A (ja) | 2006-03-09 |
AU2009213075A1 (en) | 2009-10-08 |
US20130330330A1 (en) | 2013-12-12 |
AU2009213075B8 (en) | 2012-07-19 |
US8524227B2 (en) | 2013-09-03 |
US20080033148A1 (en) | 2008-02-07 |
WO2003083062A8 (en) | 2005-04-28 |
CA2480163A1 (en) | 2003-10-09 |
US20040023341A1 (en) | 2004-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL164181A0 (en) | Anti-il-tif antibodies and methods of using in inflammation | |
EP1482984A4 (en) | REPLACEMENT ANTIBODIES AND METHOD FOR THEIR MANUFACTURE AND USE | |
EP1549756A4 (en) | RECOMBINANT MUTANTS OF RHABDOVIRUS AND METHODS OF USE | |
EP1546112A4 (en) | IMIDAZOLOPYRIDINE AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
IL225633A0 (en) | Antibodies against alpha v beta 6 and uses thereof | |
EP1551875A4 (en) | TAMPON PREPARATIONS FOR CONCENTRATING ANTIBODIES AND METHODS FOR USE THEREOF | |
IL172689A0 (en) | Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE | |
HK1079789A1 (zh) | 血管靜態毒性試劑及其使用方法 | |
AU2003265522A1 (en) | FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF | |
AU2003216591A8 (en) | Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological | |
AU2003224890A1 (en) | Drug-complex microparticles and methods of making/using same | |
AU2003277259A8 (en) | Immunoassay and method of use | |
EP1476150A4 (en) | CARBOXY FULLERES AND USE METHOD THEREFOR | |
EP1581637A4 (en) | MATERIALS AND METHODS WITH HUMAN STEM CELLS | |
AU2003219093A8 (en) | Anti-hpv-16 e7 antibodies and their use | |
AU2003215244A8 (en) | Complexes and methods of using same | |
EP1491091A4 (en) | MEANS OF PROTECTION AGAINST INSECTS AND METHODS OF PROTECTION AGAINST INSECTS | |
IL166063A0 (en) | Antibodies and uses thereof | |
AU2003276844A8 (en) | Formulations of modified antibodies and methods of making the same | |
AU2003209289A8 (en) | Transposable elements in rice and methods of use | |
AU2003282593A8 (en) | Polyphenolamine composition and method of use | |
AU2003276398A8 (en) | Shearwall structure and method of making the same | |
EP1633850A4 (en) | OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE | |
EP1549951A4 (en) | SEMAPHORIN-LIKE PROTEINS AND METHODS OF USE THEREOF | |
GB0222695D0 (en) | Improvements in and relating to methods of colouring materials |